
Weekly Dose: Keytruda may be a miracle cancer drug, but can those who need it afford it?
Nicholas Huntington, Walter and Eliza Hall Institute Keytruda (generic name pembrolizumab) is an immunotherapy drug…
Nicholas Huntington, Walter and Eliza Hall Institute Keytruda (generic name pembrolizumab) is an immunotherapy drug…
The Therapeutic Goods Administration has approved pembrolizumab (KEYTRUDA 200mg, every three weeks) as monotherapy for…
Richard De Abreu Lourenco, University of Technology Sydney; Marion Haas, University of Technology Sydney, and…
Researchers have identified for the first time how a new class of epigenetic drug engages with…
The ABC. Patients with advanced skin cancer will soon have affordable access to a promising…